186 related articles for article (PubMed ID: 22471956)
1. Treating depression in coronary artery disease and chronic heart failure: what's new in using selective serotonin re-uptake inhibitors?
Paraskevaidis I; Palios J; Parissis J; Filippatos G; Anastasiou-Nana M
Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):109-15. PubMed ID: 22471956
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin re-uptake inhibitors for the treatment of depression in coronary artery disease and chronic heart failure: evidence for pleiotropic effects.
Paraskevaidis I; Parissis JT; Fountoulaki K; Filippatos G; Kremastinos D
Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):361-7. PubMed ID: 17073612
[TBL] [Abstract][Full Text] [Related]
3. Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors.
van Melle JP; de Jonge P; van den Berg MP; Pot HJ; van Veldhuisen DJ
Drugs; 2006; 66(16):2095-107. PubMed ID: 17112303
[TBL] [Abstract][Full Text] [Related]
4. Sertraline for the treatment of depression in coronary artery disease and heart failure.
Parissis J; Fountoulaki K; Paraskevaidis I; Kremastinos DT
Expert Opin Pharmacother; 2007 Jul; 8(10):1529-37. PubMed ID: 17661734
[TBL] [Abstract][Full Text] [Related]
5. The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis.
Fernandes N; Prada L; Rosa MM; Ferreira JJ; Costa J; Pinto FJ; Caldeira D
Clin Res Cardiol; 2021 Feb; 110(2):183-193. PubMed ID: 32617669
[TBL] [Abstract][Full Text] [Related]
6. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
Serebruany VL; Glassman AH; Malinin AI; Nemeroff CB; Musselman DL; van Zyl LT; Finkel MS; Krishnan KR; Gaffney M; Harrison W; Califf RM; O'Connor CM;
Circulation; 2003 Aug; 108(8):939-44. PubMed ID: 12912814
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure.
Andrade C; Kumar CB; Surya S
Int Clin Psychopharmacol; 2013 May; 28(3):145-55. PubMed ID: 23325305
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting.
Xiong GL; Jiang W; Clare R; Shaw LK; Smith PK; Mahaffey KW; O'Connor CM; Krishnan KR; Newby LK
Am J Cardiol; 2006 Jul; 98(1):42-7. PubMed ID: 16784918
[TBL] [Abstract][Full Text] [Related]
9. The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study.
Leftheriotis D; Flevari P; Ikonomidis I; Douzenis A; Liapis C; Paraskevaidis I; Iliodromitis E; Lykouras L; Kremastinos DT
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1217-23. PubMed ID: 20487349
[TBL] [Abstract][Full Text] [Related]
10. Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications.
Parissis JT; Fountoulaki K; Filippatos G; Adamopoulos S; Paraskevaidis I; Kremastinos D
Int J Cardiol; 2007 Mar; 116(2):153-60. PubMed ID: 16822560
[TBL] [Abstract][Full Text] [Related]
11. Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used.
Fosbøl EL; Gislason GH; Poulsen HE; Hansen ML; Folke F; Schramm TK; Olesen JB; Bretler DM; Abildstrøm SZ; Sørensen R; Hvelplund A; Køber L; Torp-Pedersen C
Circ Heart Fail; 2009 Nov; 2(6):582-90. PubMed ID: 19919983
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin.
Serebruany VL; Glassman AH; Malinin AI; Atar D; Sane DC; Oshrine BR; Ferguson JJ; O'Connor CM
Eur J Heart Fail; 2003 Aug; 5(4):517-21. PubMed ID: 12921813
[TBL] [Abstract][Full Text] [Related]
13. Crucial interactions between selective serotonin uptake inhibitors and sigma-1 receptor in heart failure.
Bhuiyan MS; Tagashira H; Fukunaga K
J Pharmacol Sci; 2013; 121(3):177-84. PubMed ID: 23428811
[TBL] [Abstract][Full Text] [Related]
14. Treatment of depression in patients with congestive heart failure.
Shapiro PA
Heart Fail Rev; 2009 Mar; 14(1):7-12. PubMed ID: 17955364
[TBL] [Abstract][Full Text] [Related]
15. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
Nair GV; Gurbel PA; O'Connor CM; Gattis WA; Murugesan SR; Serebruany VL
Am J Cardiol; 1999 Aug; 84(3):321-3, A8. PubMed ID: 10496443
[TBL] [Abstract][Full Text] [Related]
16. [Depression, stress and coronary heart disease--epidemiology, prognosis and therapeutic sequelae].
Follath F
Ther Umsch; 2003 Nov; 60(11):697-701. PubMed ID: 14669708
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression.
Tousoulis D; Antoniades C; Drolias A; Stefanadi E; Marinou K; Vasiliadou C; Tsioufis C; Toutouzas K; Latsios G; Stefanadis C
J Card Fail; 2008 Aug; 14(6):456-64. PubMed ID: 18672192
[TBL] [Abstract][Full Text] [Related]
18. Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?
Schlienger RG; Meier CR
Am J Cardiovasc Drugs; 2003; 3(3):149-62. PubMed ID: 14727927
[TBL] [Abstract][Full Text] [Related]
19. Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.
Wozniak G; Toska A; Saridi M; Mouzas O
Med Sci Monit; 2011 Sep; 17(9):RA205-14. PubMed ID: 21873959
[TBL] [Abstract][Full Text] [Related]
20. [Ischemic heart disease and depression: an underestimated clinical association].
Pizzi C; Santarella L; Manfrini O; Chiavaroli M; Agushi E; Cordioli E; Costa GM; Bugiardini R
G Ital Cardiol (Rome); 2013; 14(7-8):526-37. PubMed ID: 23877550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
